These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 30445584
21. Extra intestinal manifestations and complications in inflammatory bowel disease. Marineaţă A, Rezuş E, Mihai C, Prelipcean CC. Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):279-88. PubMed ID: 25076688 [Abstract] [Full Text] [Related]
27. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D. Acta Dermatovenerol Croat; 2016 Apr 14; 24(1):83-5. PubMed ID: 27149138 [Abstract] [Full Text] [Related]
28. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Isaacs KL. Inflamm Bowel Dis; 2008 Oct 14; 14 Suppl 2():S198-9. PubMed ID: 18816779 [No Abstract] [Full Text] [Related]
29. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, Das K. Indian J Gastroenterol; 2015 Sep 14; 34(5):387-94. PubMed ID: 26614005 [Abstract] [Full Text] [Related]
30. Extraintestinal manifestations of inflammatory bowel disease. Williams H, Walker D, Orchard TR. Curr Gastroenterol Rep; 2008 Dec 14; 10(6):597-605. PubMed ID: 19006617 [Abstract] [Full Text] [Related]
35. Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease. Andrisani G, Guidi L, Papa A, Armuzzi A. Eur Rev Med Pharmacol Sci; 2012 Jul 14; 16(7):890-901. PubMed ID: 22953637 [Abstract] [Full Text] [Related]
36. Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Drugs; 2021 Feb 14; 81(3):333-347. PubMed ID: 33400241 [Abstract] [Full Text] [Related]
37. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease. Brown SR, Coviello LC. Surg Clin North Am; 2015 Dec 14; 95(6):1245-59, vii. PubMed ID: 26596925 [Abstract] [Full Text] [Related]
38. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F, European Crohn’s and Colitis Organisation. J Crohns Colitis; 2016 Mar 14; 10(3):239-54. PubMed ID: 26614685 [No Abstract] [Full Text] [Related]
39. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases. Reinshagen M, von Tirpitz C. Dig Dis; 2003 Mar 14; 21(2):138-45. PubMed ID: 14571111 [No Abstract] [Full Text] [Related]